OMKAR PHARMACHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve and take on record the Unaudited Financial Results of the Company for the Quarter ended on 30th June, 2023.

pdf

Omkar Pharmachem Ltd.

14 Jul 2023

26.77

4.98%

Company Update

OMKAR PHARMACHEM LTD. - 532167 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance Certificate under regulation 74 (5) of SEBI (DP) Regulations, 2018 for the Quarter ended on 30th June 2023

pdf

Omkar Pharmachem Ltd.

29 Jun 2023

26.77

4.98%

SAST

OMKAR PHARMACHEM LTD. - 532167 - Closure of Trading Window

BSE India

Dear Sir, Pursuant to SEBI (Prohibition of Insider Trading Regulations), 2015 as amended and in Compliance with the terms of Code of Conduct of the company, please note that Trading Window for dealing in the securities of the company will remain closed for the designated persons and their immediate relatives from July 01, 2023 till the completion of 48 Hrs after the date of declaration of Unaudited Financial Results of the company for the quarter ended on June 30, 2023.

pdf

Omkar Pharmachem Ltd.

31 May 2023

26.77

4.98%

Company Update

OMKAR PHARMACHEM LTD. - 532167 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Dear Sir, Please find enclosed herewith copy of newspapers advertisement in which Audited financial results for the quarter and Year ended on 31stMarch2023 are published, one in vernacular language and one in English newspaper.

pdf

Omkar Pharmachem Ltd.

30 May 2023

26.77

4.98%

Company Update

OMKAR PHARMACHEM LTD. - 532167 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Dear Sir, With reference to Captioned subject and pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please note that Mr. Amit Jain has appointed as Chief Financial Officer and Key Managerial Personnel (KMP) of the company with effect from 30th May 2023 as per the provisions of section 203 of Companies Act, 2013 and rules made thereunder.

pdf

Omkar Pharmachem Ltd.

30 May 2023

26.77

4.98%

Result

OMKAR PHARMACHEM LTD. - 532167 - Results-Financial Results For March 31 2023

BSE India

Dear Sir(s), Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please find enclosed herewith: 1.Audited Financial Results of the Company, for the Quarter and Financial year ended on 31st March, 2023, alongwith the Auditor''s Report on Audited Financial results by statutory auditor of the Company. 2.Statement of Asset and Liabilities of the Company. 3.Cash Flow Statement. 4.Declaration under Regulation 33(3)(d) of SEBI (Listing Obligations and Discloser Requirement) Regulation 2015.

pdf

Omkar Pharmachem Ltd.

30 May 2023

26.77

4.98%

Board Meeting

OMKAR PHARMACHEM LTD. - 532167 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held on 30th May, 2023 has considered and approved the following business: Audited Financial Results of the Company for the quarter and year ended on 31st March, 2023.

pdf

Is Omkar Pharmachem Ltd. worth buying?

2 Votes:

Buy 100.0%